medigraphic.com
ISSN 1029-3019 (Electronic)

2019, Number 03

<< Back Next >>

MediSan 2019; 23 (03)

Maxillofacial manifestations in patients with rheumatoid arthritis

Alemán MO, Aput NA, Domínguez RY, Jardón CJ, Nápoles PDD

Language: Spanish
References: 15
Page: 460-467
PDF size: 812.83 Kb.


ABSTRACT

Introduction: Rheumatoid arthritis is a systemic inflammatory chronic disease characterized by an autoimmune reaction and it can produce oral and facial manifestations.
Objective: To describe the maxillofacial manifestations of the rheumatoid arthritis.
Methods: An observational, descriptive series of cases study, of 25 patients with rheumatoid arthritis, randomly selected, who were admitted in the Rheumatology Service of Saturnino Lora Torres Teaching Clinical-Surgical Provincial Hospital in Santiago de Cuba was carried out, from September, 2016 to February, 2017, to whom an intraoral and extraoral detailed physical examination was made.
Results: The intraoral localization where more manifestations existed was the protection periodonto (84.0 %), followed by the insertion periodonto (40.0 %). As for the extraoral manifestations, they were scarce, with a mild prevalence of damage in the parotid region (32.0 %). Most of the series presented temporomandibular joint changes (80.0 %) and periodontopathies (84.0 %); while a small minority suffered ulcerations and black stains (with 12.0 % each).
Conclusions: In this investigation considerable changes of the oral complex were identified, such as periodontopathies, changes of the temporomandibular joint, among other that can influence negatively in the life quality of these patients.


REFERENCES

  1. Kaur S, White S, Bartold PM. Periodontal disease and rheumatoid arthritis: a systematic review. J Dent Res. 2013;92(5):399-408.

  2. Bykerk VP, Schoels MM. Treatment strategies for early rheumatoid arthritis. Curr Opin Rheumatol. 2013;25(3):375-83.

  3. Coelho Horimoto AM, Pereira da Costa I. Sobreposição de esclerose sistêmica e artrite reumatoide: uma entidade clínica distinta? Rev Bras Reum. 2016 [citado 15/02/2018];56(4):287-98. Disponible en: https://reader.elsevier.com/reader/sd/pii/S0482500415000303?token=41A2022D62A25374A9BEC70D921F41B53712584B5C1D73BD7110F975D691EB0CAF91C237DB630A09BCA8B2B45A1CBA03

  4. Goes P, Chagas Coelho A, Carvalho Oliveira C. Efeito da raspagem e alisamento radicular em pacientes com artrite reumatoide: revisão da literatura. Rev Fac Odontol Lins/Unimep. 2014;24(1):33-40.

  5. Silvestre Rangil J. Manifestaciones orales del paciente con artritis reumatoide. Valencia: Universitat de València; 2014 [citado 15/02/2018]. Disponible en: http://roderic.uv.es/bitstream/handle/10550/37980/tesis.pdf?sequence=1&isAllowed=y

  6. Okada M, Kobayashi T, Ito S, Yokoyama T, Abe A, Murasawa A, et al. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis. J Periodontol. 2013;84(12):74-84.

  7. Prasad M, Hermann J, Gabriel SE, Weyand CM, Mulvagh S, Mankad R, et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol. 2015; 12(3): 168-76.

  8. Fidelix TS, Vieira L, Freitas D, Trevisani VF. Biology therapy for refractory scleritis: a new treatment perspective. Int Ophthalmol. 2015;35(6):903-5.

  9. Jeon HS, Hyon JY, Kim MK, Chung TY, Yoon KC, Kim JY, et al. Efficacy and safety of immunosuppressive agents in the treatment of necrotising scleritis: a retrospective, multicentre study in Korea. Br J Ophthalmol. 2016;100(8):1066-70.

  10. Cornish KS, Kuffova L, Forrester JV. Treatment of diffuse subretinal fibrosis uveitis with rituximab. Br J Ophthalmol. 2015; 99(2):153-4.

  11. Chávez Andrade GM, Tavares da Silva RHB, Villela de Berbert F, De Ribeiro AP. Hallazgos clínico-radiológicos de la articulación temporomandibular en pacientes con artritis reumatoide. Rev Cubana Estomatol. 2009 [citado 18/02/2018];46(2):9-10. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75072009000200005

  12. Alba Fériz R, Muñoz Louis R. Enfermedades inflamatorias reumatológicas. Santo Domingo: FUNDERIC; 2016. p. 120-24.

  13. Kesarwala AH, Krishna MC, Mitchell JB. Oxidative stress in oral diseases. Oral Dis. 2016 [citado 15/02/2018];22(1):9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442080/

  14. Wang J, Schipper HM, Velly AM, Mohit S, Gornitsky M. Salivary biomarkers of oxidative stress: A critical review. Free Radic Biol Med. 2015;85:95-104.

  15. Tóthová L, Kamodyová N, Cervenka T, Celec P. Salivary markers of oxidative stress in oral diseases. Front Cell Infect Microbiol. 2015 [citado 15/02/2018];5:73. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611854/




2020     |     www.medigraphic.com